Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes

Gros, A., Tran, E., Parkhurst, M. R., Anna, P., Ilyas, S., Prickett, T. D., … Rosenberg, S. A. (2015). Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes. Journal for ImmunoTherapy of Cancer, 3. https://doi.org/10.1186/2051-1426-3-S2-O2